- Chronic Diseases / Disorders
- Fetal Alcohol Spectrum Disorder (FASD)
- Health Economics / Healthcare Costs
- Health Measurement Tools
- Health Policy
- Healthcare Services
- Infectious Diseases
- Maternal and Child Health
- Mental Health
- Quality of Life
Ovulation Induction Drug Therapy for Anovulatory Infertility Associated with Polycystic Ovary Syndrome
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #33.
This report is a systematic review and critical appraisal of the evidence on the use of ovulation induction (OI) drug therapy to manage anovulatory infertility associated with polycystic ovary syndrome (PCOS) in women of reproductive age. The aim was to provide the current published scientific evidence about its safety and efficacy/effectiveness in terms of pregnancy rate in this category of infertile patients in response to a request for information from Alberta Health and Wellness.
NOTE: In 2006 the Alberta Heritage Foundation for Medical Research HTA unit moved to IHE. Documents produced in and prior to 2006 have different formats; the format was determined by the agency for which the document was produced.
Health Technology Assessments /
Year of Publication: 2004
Topics: Maternal and Child Health, Therapy
Authors: Paula Corabian, Ann Scott
ISBN (print): 1-896956-85-8
ISBN (online): 1-896956-87-4
ISSN (online): 1704-1104